Douglas Ball

Title: Douglas Ball: Innovator in Oncolytic Virus Therapy

Introduction

Douglas Ball is a prominent inventor based in Calgary, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on utilizing oncolytic viruses to enhance the effectiveness of radiation therapy for neoplastic cells.

Latest Patents

Douglas Ball holds a patent titled "Sensitization of neoplastic cells to radiation therapy with reovirus." This invention relates to methods of sensitizing neoplastic cells to irradiation by using oncolytic viruses, particularly reoviruses. The patent also outlines methods for treating or ameliorating tumors through a combination of oncolytic viruses and radiotherapy.

Career Highlights

Douglas Ball is associated with Oncolytics Biotech Inc., a company dedicated to advancing cancer therapies. His work has been instrumental in developing innovative approaches to cancer treatment, particularly through the use of oncolytic viruses.

Collaborations

Throughout his career, Douglas has collaborated with notable colleagues, including Donald Morris and Matthew C. Coffey. These collaborations have furthered research and development in the field of oncolytic virus therapy.

Conclusion

Douglas Ball's contributions to cancer treatment through his patent and work at Oncolytics Biotech Inc. highlight the potential of oncolytic viruses in enhancing radiation therapy. His innovative approach continues to pave the way for advancements in cancer research and treatment.